Pancreatic Cancer Clinical Trials
Find clinical trials for pancreatic cancer. Search for pancreatic cancer clinical trials in different cities and states across the United States.
Observational StudyPancreatic Cancer Early Detection Consortium
Sponsor:
Arbor Research Collaborative for Health
Location:
Code:
NCT04970056
Conditions
Pancreas Cancer
Pancreas Cyst
Pancreatic Ductal Adenocarcinoma
Genetic Predisposition
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Accepted
CyberknifeA Study of Pre-Operative Cyberknife in Patients With Potentially Resectable Pancreas Cancer
Sponsor:
The Cooper Health System
Location:
Code:
NCT02707315
Conditions
Pancreas Cancer
Pancreatic Cancer
Adenocarcinoma of the Pancreas
Pancreas Adenocarcinoma
Pancreatic Adenocarcinoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Gemcitabine
Stereotactic Radiosurgery
M9140Study of Anti-CEACAM5 ADC M9140 in Participants With Advanced Solid Tumors (PROCEADE PanTumor)
Sponsor:
EMD Serono Research & Development Institute, Inc.
Location:
Code:
NCT06710132
Conditions
Solid Tumors
Gastric Cancer
Non-Small Cell Lung Cancer (NSCLC)
Pancreatic Cancer
Pancreatic Ductal Adenocarcinoma (PDAC)
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
M9140
M3814 with RadiotherapyTesting the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer
Sponsor:
National Cancer Institute (NCI)
Location:
Code:
NCT04172532
Conditions
Locally Advanced Pancreatic Adenocarcinoma
Stage III Pancreatic Cancer AJCC v8
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Biopsy Procedure
Biospecimen Collection
Computed Tomography
Hypofractionated Radiation Therapy
Magnetic Resonance Imaging
Radiotherapy & ChemotherapyRadiotherapy With Chemotherapy as Neoadjuvant Therapy of Resectable and Borderline Resectable Pancreas Cancer
Sponsor:
University of Virginia
Location:
Code:
NCT01333332
Conditions
Pancreatic Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Capecitabine
Standard Dose Acclerated Fraction Radiotherapy
Interested in new trials?
Get alerts for new trials in your area by subscribing now
PEGPH20 & PembroSecond-line Study of PEGPH20 and Pembro for HA High Metastatic PDAC
Sponsor:
Pancreatic Cancer Research Team
Location:
Code:
NCT03634332
Conditions
Pancreatic Ductal Adenocarcinoma
Pancreatic Cancer
Pancreatic Neoplasms
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
PEGPH20
Pembrolizumab
ZN-c3 & GemcitabineZN-c3 + Gemcitabine in Pancreatic Cancer
Sponsor:
Brandon Huffman, MD
Location:
Code:
NCT06015659
Conditions
Advanced Pancreatic Adenocarcinoma
Pancreatic Cancer
Pancreatic Ductal Adenocarcinoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Zentalis
Gemzar
PET ImagingPET Imaging Using 64Cu-Tz-SarAr and hu5B1-TCO in People With Pancreatic, Colorectal, Bladder Cancer or Cancers With Elevated CA19.9
Sponsor:
Memorial Sloan Kettering Cancer Center
Location:
Code:
NCT05737615
Conditions
Pancreatic Cancer
Pancreatic Ductal Adenocarcinoma
Metastatic Pancreatic Ductal Adenocarcinoma
Primary Pancreatic Ductal Adenocarcinoma
Metastatic Pancreatic Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
PET Scan
hu5B1-TCO
64Cu-Tz-SarAr
Pharmacokinetics
Neoadjuvant ChemotherapyPurIST Classification-Guided Adaptive Neoadjuvant Chemotherapy by RNA Expression Profiling of EUS Aspiration Samples
Sponsor:
Medical College of Wisconsin
Location:
Code:
NCT04683315
Conditions
Pancreatic Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
mFOLFIRINOX Treatment Regimen
Gemcitabine/Nab-paclitaxel Treatment Regimen
Chemoradiation